Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum

Preclinical evidence suggests that metformin, a widely used antidiabetic drug, may have a sensitizing effect on platinum. The purpose of this study was to evaluate the survival outcomes for non-small cell lung cancer (NSCLC) patients with type 2 diabetes mellitus (T2DM) using metformin during platin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen-Xiu, Xin, Xiao-Wei, Zheng, Hai-Ying, Ding, Ying-Hui, Tong, Si-Si, Kong, Xiao-Fang, Zhou, Huang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320173/
https://www.ncbi.nlm.nih.gov/pubmed/30572481
http://dx.doi.org/10.1097/MD.0000000000013652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320173/
https://www.ncbi.nlm.nih.gov/pubmed/30572481
http://dx.doi.org/10.1097/MD.0000000000013652

Ejemplares similares